Table 1 Patient baseline characteristics

Age

 Median

57

 Range

24–78

Sex

 Female

14

 Male

14

Soft tissue sarcoma

24

Bone sarcoma

4

Location

 Extremity

6

 Abdomen/pelvis

12

 Axial

2

 Head/neck

5

 Chest

3

Stage

 IV

26

 Unresectable

2

ECOG PS

 0–1

24

 2

4

Nivolumab

 Cycles (median)

8

 Range

1–26

On Pazopanib

18

Prior treatments (including neoadjuvant/adjuvant)

 Median

2

 Range

0–6

 Anthracycline

15

 Ifosfamide

10

 Gemcitabine

9

 Docetaxel

7